B
BIIB
StockHealth CareBiogen Inc. Common Stock
$187.99
+$3.80 (+2.06%)
Price Chart
No chart data available
About Biogen Inc. Common Stock
Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases.
Market cap
$20.89B
Company information
ExchangeNASDAQ
CountryUnited States of America
CEOMichel Vounatsos
Employees7,300
Frequently Asked Questions About BIIB
The current price of Biogen Inc. Common Stock (BIIB) stock is $187.99 USD. The stock has changed +2.06% in today's trading session.
You can buy BIIB stock through Wallbit, available in 80+ countries worldwide. Simply create an account, fund it, and you can start investing in Biogen Inc. Common Stock and thousands of other US stocks.
Biogen Inc. Common Stock (BIIB) has a market capitalization of $20.89B. Market cap is calculated by multiplying the current stock price by the total number of outstanding shares.
Biogen Inc. Common Stock (BIIB) operates in the Health Care sector. This classification helps investors understand the company's primary business activities and compare it with similar companies.
The current CEO of Biogen Inc. Common Stock (BIIB) is Michel Vounatsos. The CEO is responsible for the company's overall strategic direction and day-to-day operations.
Biogen Inc. Common Stock (BIIB) has approximately 7,300 employees worldwide.
Biogen Inc. Common Stock (BIIB) is listed on the NASDAQ. Trading hours are typically Monday through Friday, 9:30 AM to 4:00 PM Eastern Time.